Richard B. Saltman, Reinhard Busse, Josep Figueras
Series editors ’ introduction European national policy makers broadly agree on the core objectives that their health care systems should pursue. The list is strikingly straightforward: universal...
Richard B. Saltman, Reinhard Busse, Elias Mossialos, Regulating Entrepreneurial
The series The volumes in this series focus on key issues for health policy-making in Europe. Each study explores the conceptual background, outcomes and lessons learned about the development of more...
MANAGEMENT FOR PHARMACEUTICAL INNOVATIONS vorgelegt von (2008)
Virginie Annelaure, Schubert Tang, Von Fakultät, Viii Wirtschaft Management, Doktor Der Wirtschaftswissenschaften, Vorsitzende Prof, ...
This thesis consists of four parts. The first part conducts a generic literature study on customer relationship management practices for innovations. It discusses management of innovations and the...
Stargardt, Tom, Weinbrenner, Susanne, Busse, Reinhard, Juckel, Georg, Gericke, Christian Ansgar Otto
Copyright © 2008 ICMPE
Stargardt, Tom, Weinbrenner, Susanne, Busse, Reinhard, Juckel, Georg, Gericke, Christian Ansgar Otto
Copyright © 2008 ICMPE
Weinbrenner, Susanne, Assion, H. J., Stargardt, Tom, Busse, Reinhard, Juckel, Georg, Gericke, Christian Ansgar Otto
S. Weinbrenner, H.-J. Assion, T. Stargardt, R. Busse, G. Juckel, C. A. Gericke
Weinbrenner, Susanne, Assion, H. J., Stargardt, Tom, Busse, Reinhard, Juckel, Georg, Gericke, Christian Ansgar Otto
S. Weinbrenner, H.-J. Assion, T. Stargardt, R. Busse, G. Juckel, C. A. Gericke
Ethical issues in funding orphan drug research and development (2005)
Gericke, Christian Ansgar Otto, Riesberg, A., Busse, Reinhard
Copyright © 2005 BMJ Publishing Group Ltd & Institute of Medical Ethics
Ethical issues in funding orphan drug research and development (2005)
Gericke, Christian Ansgar Otto, Riesberg, A., Busse, Reinhard
Copyright © 2005 BMJ Publishing Group Ltd & Institute of Medical Ethics
Health Care Reform in Germany: Patchwork Change within Established Governance Structures (2005)
Altenstetter, Christa, Busse, Reinhard
Under the pressure of health care reform in the 1990s, interactions among the state, sickness funds, and providers in Germany are said to have entered a new era. We examine this new era by assessing...
Policies for disease prevention in Germany in the European context: a comparative analysis (2004)
Gericke, Christian Ansgar Otto, Busse, Reinhard
Copyright Journal of Public Health 26(3) © Faculty of Public Health 2004; all rights reserved.
Policies for disease prevention in Germany in the European context: a comparative analysis (2004)
Gericke, Christian Ansgar Otto, Busse, Reinhard
Copyright Journal of Public Health 26(3) © Faculty of Public Health 2004; all rights reserved.
Policies for disease prevention in Germany in the European context: a comparative analysis (2004)
Gericke, Christian A., Busse, Reinhard
Background In Europe important differences exist concerning policies for the prevention of common diseases. In most cases these cannot be explained by the underlying epidemiology. However, successful...
Risk structure compensation in Germanys statutory health insurance (2001)
In 1996 insurees in Germany’s statutory health insurance system were given a right to choose their sickness fund. To ensure that all funds had an equal starting position, a risk structure...
Markus M. Grabka, Jonas Schreyögg, Reinhard Busse
As part of the Statutory Health Insurance Modernization Act a co-payment of €10 per quarter for the first contact at a physician's or a dentist's office has been introduced with effect of 1st...
Busse, Reinhard, Stargardt, Tom, Schreyögg, Jonas
The issue of defining health benefit catalogues has recently gained new importance in Germany as a result of the creation of the new Institute for Quality and Efficiency. The Institute was designed...
Cost accounting to determine prices: How well do prices reflect costs in the German DRG-system?
Jonas Schreyögg, Oliver Tiemann, Reinhard Busse
Germany has recently introduced a system of Diagnosis Related Groups (DRGs) to engender more appropriate resource allocation. The following article describes the German DRG-system and the...
Jonas Schreyögg, Tom Stargardt, Oliver Tiemann, Reinhard Busse
Over the past 20 years, most European countries have introduced DRGs or similar grouping systems as instruments for hospital reimbursement. This paper compares and analyzes the methods used to...
Editorial: Hospital case payment systems in Europe
Reinhard Busse, Jonas Schreyögg, Peter Smith
Since the introduction of the system of diagnosis related groups (DRGs) for USA Medicare patients in 1983, case payment mechanisms have gradually become the principal means of reimbursing hospitals...
Busse, Reinhard, Stargardt, Tom, Schreyögg, Jonas
The issue of defining health benefit catalogues has recently gained new importance in Germany as a result of the creation of the new Institute for Quality and Efficiency. The Institute was designed...
Hospitalisation Costs of Cystic Fibrosis
Jonas Schreyogg, Helge Hollmeyer, Miriam Bluemel, Doris Staab, Reinhard Busse
Objective: To calculate per-case hospital costs for patients with cystic fibrosis under routine conditions from a healthcare provider's perspective; identify the impact of different cost categories;...
Jonas Schreyögg, Oliver Tiemann, Tom Stargardt, Reinhard Busse
International comparisons of healthcare costs are growing in importance for a number of different applications. The use of common approaches to converting costs such as GDP purchasing power parities...
Reinhard Busse, Jonas Schreyögg, Peter C. Smith
No Abstract
Christian Krauth, Noushin Jalilvand, Tobias Welte, Reinhard Busse
Cystic fibrosis (CF) is the most common life-shortening inherited disease of the Caucasian race, with a prevalence of around 1 in 2500 live births. Advances in the treatment and management of...
Analysing the impact of health-care system change in the EU member states - Germany
The core of the German health-care system is the statutory health insurance (SHI). Coverage of the SHI has remained fairly constant at about 90% whereas the rest of the population is insured for the...
Regulation of health-related technologies in Germany
Perleth, Matthias, Busse, Reinhard, Schwartz, Friedrich Wilhelm
Balancing adoption and affordability of medical devices in Europe
Schreyögg, Jonas, Bäumler, Michael, Busse, Reinhard
Dramatic increases in health expenditures have led to a substantial number of regulatory interventions in the markets for devices over the last years. However, little attention has been paid thus far...